135 related articles for article (PubMed ID: 26486693)
1. Trends in incidence and survival for upper tract urothelial cancer (UTUC) in the state of Victoria--Australia.
Woodford R; Ranasinghe W; Aw HC; Sengupta S; Persad R
BJU Int; 2016 Apr; 117 Suppl 4():45-9. PubMed ID: 26486693
[TBL] [Abstract][Full Text] [Related]
2. Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985-2010.
Eylert MF; Hounsome L; Verne J; Bahl A; Jefferies ER; Persad RA
BJU Int; 2013 Jul; 112(2):E107-13. PubMed ID: 23470094
[TBL] [Abstract][Full Text] [Related]
3. Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population-based study from 1993 to 2017.
van Doeveren T; van der Mark M; van Leeuwen PJ; Boormans JL; Aben KKH
BJU Int; 2021 Sep; 128(3):343-351. PubMed ID: 33690922
[TBL] [Abstract][Full Text] [Related]
4. Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005.
Raman JD; Messer J; Sielatycki JA; Hollenbeak CS
BJU Int; 2011 Apr; 107(7):1059-64. PubMed ID: 20825397
[TBL] [Abstract][Full Text] [Related]
5. Recent trends in incidence, mortality, survival, and treatment of upper tract urothelial carcinoma.
Ma Z; Yi Y; Qiu Z
Fr J Urol; 2024 Mar; 34(2):102573. PubMed ID: 38330829
[TBL] [Abstract][Full Text] [Related]
6. Secondary bladder cancer after upper tract urothelial carcinoma in the US population.
Kates M; Badalato GM; Gupta M; McKiernan JM
BJU Int; 2012 Nov; 110(9):1325-9. PubMed ID: 22564365
[TBL] [Abstract][Full Text] [Related]
7. Higher than expected and significantly increasing incidence of upper tract urothelial carcinoma. A population based study.
Almås B; Halvorsen OJ; Johannesen TB; Beisland C
World J Urol; 2021 Sep; 39(9):3385-3391. PubMed ID: 33420812
[TBL] [Abstract][Full Text] [Related]
8. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
[TBL] [Abstract][Full Text] [Related]
9. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI
Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727
[TBL] [Abstract][Full Text] [Related]
10. Factors impacting survival in patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy.
Mouracade P; Velten M; Gigante M; Alenda O; Ploussard G; Obadia F; Timsit MO; Mejean A
Can J Urol; 2012 Feb; 19(1):6105-10. PubMed ID: 22316512
[TBL] [Abstract][Full Text] [Related]
11. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades.
Munoz JJ; Ellison LM
J Urol; 2000 Nov; 164(5):1523-5. PubMed ID: 11025695
[TBL] [Abstract][Full Text] [Related]
12. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
[TBL] [Abstract][Full Text] [Related]
13. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population.
Fang D; Xiong G; Li X; Kang Y; Zhang L; Zhao G; Chen X; Yao L; Zhang X; Yu W; Gong K; Song Y; He Q; He Z; Zhou L; Guo Y
Urol Oncol; 2015 Feb; 33(2):66.e1-11. PubMed ID: 25240760
[TBL] [Abstract][Full Text] [Related]
14. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
15. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma.
Abouassaly R; Alibhai SM; Shah N; Timilshina N; Fleshner N; Finelli A
Urology; 2010 Oct; 76(4):895-901. PubMed ID: 20646743
[TBL] [Abstract][Full Text] [Related]
16. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy.
Miest T; Khanna A; Sharma V; Hensley PJ; Campbell R; Thapa P; Zganjar A; Tollefson MK; Thompson RH; Frank I; Karnes RJ; Potretzke A; Matin SF; Murthy PB; Haber GP; Lee B; Boorjian SA
J Urol; 2022 Feb; 207(2):284-292. PubMed ID: 34547921
[TBL] [Abstract][Full Text] [Related]
18. Survival after nephroureterectomy for upper tract urothelial carcinoma: a population-based competing-risks analysis.
Gandaglia G; Bianchi M; Trinh QD; Becker A; Larouche A; Abdollah F; Roghmann F; Tian Z; Shariat SF; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Int J Urol; 2014 Mar; 21(3):249-56. PubMed ID: 24033809
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
[TBL] [Abstract][Full Text] [Related]
20. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
